FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stimulator, Autonomic Nerve, Implanted For Epilepsy

PMA: P970003 · Supplement: S245 · Decision Nov 14, 2024
Classifications
1
FEI Numbers
1
Registration Numbers
1

Basic Information

Device Name
Stimulator, Autonomic Nerve, Implanted For Epilepsy
Trade Name
VNS Therapy System
PMA Number
P970003
Supplement Number
S245
Device Class
FDA Class 3
Product Code
LYJ
Generic Name
STIMULATOR, AUTONOMIC NERVE, IMPLANTED FOR EPILEPSY
Medical Specialty
Unknown
Advisory Committee
Neurology
Decision
Approved
Decision Code
APPR
Decision Date
November 14, 2024
Date Received
October 15, 2024
Supplement Type
Special (Immediate Track)
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N

Advisory Committee Statement

VNS Therapy Physician’s Manuals (Epilepsy and Depression): Update to the Warnings, Device Diagnostics, and General Troubleshooting sections to add information related to a Potential Loss of Function due to a stuck-closed reed switch. Additional update to the technical language to refer to the magnetic sensor more generally instead of specifying a “reed switch” to allow other technologies to be used without requiring additional labeling updates.• VNS Therapy Patient Guides (Epilepsy and Depression): Updates to the General Warnings, “How the Magnet Works”, General Malfunction, and Frequently Asked Questions to add information related to device malfunctions, and specifically potentially malfunction of the sensor in the M1000 or M1000-D device. Additionally, updates to remove unnecessary technical information about the “reed switch” and instead only provide information about the functions of the magnet.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LYJ Stimulator, Autonomic Nerve, Implanted For Epilepsy